Andere Sprachen Kissei Pharmaceutical Co., Ltd.

Aktien

881370

JP3240600001

4547

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 23.04.2024			% 5 Tage	% 1. Jan.
3.570 ^JPY	+1,28 %		-1,24 %	+15,53 %

04.01.	Kissei Pharmaceutical kauft Aktien im Wert von 251 Millionen Yen im Dezember 2023 zurück	MT
2023	Kissei Pharmaceutical Co., Ltd. und Maruishi Pharmaceutical Co., Ltd. kündigen an, dass KORSUVA®? IV-Injektionsspritze für die Dialyse 17,5ug, 25,0ug zur Behandlung von Juckreiz bei Hämodialysepatienten in Japan eingeführt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program	20.03.
Kissei Pharmaceutical : Notice Concerning Status of Acquisition and Completion of the Company's Own Shares	19.03.
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	19.03.
Kissei Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 8, 2023, has closed with 1,909,900 shares, representing 4.18% for ¥5,999.99 million.	18.03.
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01.03.
Kissei Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 2024	30.01.
Kissei Pharmaceutical Repurchases 251 Million Yen Worth of Shares in December 2023	04.01.
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	04.01.
Kissei and Maruishi Debut Injection for Dialysis-Related Itching	13.12.
Kissei Pharmaceutical : KORSUVA® IV Injection Syringe for Dialysis 17.5μg, 25.0μg and 35.0μg to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	12.12.
Kissei Pharmaceutical Co., Ltd. and Maruishi Pharmaceutical Co., Ltd. Announces KORSUVA®? IV Injection Syringe for Dialysis 17.5ug, 25.0ug to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	12.12.
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01.12.
Kissei Pharmaceutical : Introduces Natural Language Processing System	17.11.
Japanese Shares Close Lower on Tuesday After Key Economic Data	07.11.
Kissei Pharmaceutical's Fiscal H1 Attributable Profit Surges as Net Sales Gains	07.11.
Kissei Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	06.11.
Kissei Pharmaceutical Co., Ltd. Announces Second Quarter-End Dividend for the Year Ending March 31, 2024, Payable on December 4, 2023 and Provided Dividend Guidance for the Year Ending March 31, 2024	06.11.
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01.11.
Kissei Pharmaceutical Co., Ltd. Revises Consolidated Earnings Guidance for the First Half Ending September 30, 2023	27.10.23
Kissei Pharmaceutical : Notice Concerning Revisions to Financial Results Forecast	27.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Kissei Pharmaceutical Co., Ltd.

Aktien

881370

JP3240600001

4547

Andere Sprachen

Filter